Harris FRC Corporation

Holmoel, NJ 07733

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $100K
First Award Date 09/30/98
Most Recent Award Date 09/30/02

Key Personnel

Last Name Name Awards Contact
Harris Robert H Harris 3

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 03/31/05

DESCRIPTION (provided by applicant): Previous studies with ADD234037 (R-2-Acetamido-N-Benzyl-3-Methoxypropionamide) a functionalized amino acid derivative, have demonstrated its anticonvulsant and neuroprotective properties. This compound is currently being evaluated in Phase II clinical studies for its utility in the treatment of epilepsy and n...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 09/29/01

The objective of this application is to determine whether harkoseride (ADD 2340037) is potentially a safe and effective treatment for epilepsy. Specifically, two clinical studies are proposed to achieve this objective. The first is an open-label ascending dose proof of principle study in a limited number of patients to assess pharmacokinetics,...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/98 - 08/31/99

DESCRIPTION (Adapted from Applicant's Abstract): ADD234037 belongs to a chemically distinct series of compounds with demonstrated antiepileptic activity. Nonclinical studies with ADD234037 demonstrated that it is active against MES-induced seizures in mice and rats, effective in the rat hippocampal kindling mo...